Literature DB >> 16443036

Towards a science of community engagement.

Peter A Newman.   

Abstract

Mesh：

Year:  2006        PMID： 16443036     DOI： 10.1016/S0140-6736(06)68067-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

1.  "Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.

Authors:  P A Newman; S Yim; A Daley; R Walisser; R Halpenny; W Cunningham; M Loutfy
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

2.  Aligning community engagement with traditional authority structures in global health research: a case study from northern Ghana.

Authors:  Paulina O Tindana; Linda Rozmovits; Renaud F Boulanger; Sunita V S Bandewar; Raymond A Aborigo; Abraham V O Hodgson; Pamela Kolopack; James V Lavery
Journal:  Am J Public Health       Date:  2011-08-18       Impact factor: 9.308

3.  Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.

Authors:  Nicole Mamotte; Douglas Wassenaar; Jennifer Koen; Zaynab Essack
Journal:  BMC Med Ethics       Date:  2010-03-09       Impact factor: 2.652

4.  Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblinding.

Authors:  Kessuda Khowsroy; Jittima Dhitavat; Yupa Sabmee; Pataramon Laowarakul; Jutarat Wattanakitwichai; Jiraporn Auetian; Kannika Lothong; Roongtip Boondao; Sarawan Maythaarttaphong; Sunee Yaemwong; Jean-Louis Excler; Supachai Rerks-Ngarm; Punnee Pitisuttithum
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

5.  No "magic bullet": exploring community mobilization strategies used in a multi-site community based randomized controlled trial: Project Accept (HPTN 043).

Authors:  Virginia A Tedrow; Carla E Zelaya; Caitlin E Kennedy; Stephen F Morin; Gertrude Khumalo-Sakutukwa; Michael D Sweat; David D Celentano
Journal:  AIDS Behav       Date:  2012-07

6.  Community engagement in US biobanking: multiplicity of meaning and method.

Authors:  K M Haldeman; R J Cadigan; A Davis; A Goldenberg; G E Henderson; D Lassiter; E Reavely
Journal:  Public Health Genomics       Date:  2014-02-19       Impact factor: 2.000

7.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

8.  Factors influencing HIV vaccine community engagement in the urban South.

Authors:  Paula M Frew; Carlos del Rio; Sarah Clifton; Matthew Archibald; Joseph T Hormes; Mark J Mulligan
Journal:  J Community Health       Date:  2008-08

9.  How ethical is your clinical trial?

Authors:  L Miller; M Folayan; D Allman; B Nkala; L M Kasirye; L R Mingote; G Calazans; R Mburu; F Ntombela; M Ditmore
Journal:  Int J Clin Pract       Date:  2010-06-16       Impact factor: 2.503

10.  Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).

Authors:  Peter A Newman; Sung-Jae Lee; Naihua Duan; Ellen Rudy; Terry K Nakazono; John Boscardin; Lisa Kakinami; Steven Shoptaw; Allison Diamant; William E Cunningham
Journal:  Health Serv Res       Date:  2009-09-24       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.